TICAGRELOR News
TICAGRELOR currently has 2 news articles, with 14 predicted indications.
This page combines the AI-predicted indications for TICAGRELOR with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Evidence level: L5
- Predicted indications (14):
- acute coronary syndrome (99.0%)
- intermittent vascular claudication (99.0%)
- peripheral arterial disease (99.0%)
- peripheral vascular disease (99.0%)
- intracranial arteriosclerosis (100.0%)
- Monckeberg arteriosclerosis (99.9%)
- priapism (99.8%)
- ischemic disease (99.6%)
- May-Thurner syndrome (99.5%)
- livedo reticularis (99.5%)
- mesenteric vascular occlusion (99.5%)
- vascular ectasia (99.5%)
- angiodysplasia (99.3%)
- venous thromboembolism (99.3%)
Related News (2)
From wrist to research: Harnessing smartwatch data for equitable cardiovascular research
2026-09-28 cardiovascular
Source: journals.plos.org
Conference MDAngle: HFSA 2026 Amyloidosis/ATTR-CM
2026-09-28 heart disease
Source: Medscape
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.